story of the week
Patient Likelihood of Being Helped or Harmed as a Tool to Weigh Efficacy and Safety of the Different CDK4/6 Inhibitors in Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
EClinicalMedicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis
EClinicalMedicine 2023 Feb 01;56(xx)101824, L Mastrantoni, A Orlandi, A Palazzo, G Garufi, A Fabi, G Daniele, D Giannarelli, G Tortora, E BriaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.